+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oscillating Positive Expiratory Pressure (OPEP) Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5026073
  • Report
  • January 2022
  • Region: Global
  • 110 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • AirPhysio
  • Allergan plc.
  • D-R Burton Healthcare
  • Medica Holdings, LLC.
  • PARI GmbH
  • R. Cegla GmbH & Co. KG

The Oscillating Positive Expiratory Pressure (OPEP) Devices market studied is anticipated to grow with a CAGR of nearly 5.3%, during the forecast period.



Certain factors that are driving the market growth include rising prevalence of chronic pulmonary diseases and growing technological advancements.



Increased geriatric population coupled with higher incidences of chronic conditions drive the OPEP devices market growth. Increasing prevalence of chronic obstructive pulmonary disease (COPD) along with asthma is one of the major driving factors for the industry.



For instance, according to CDC (the Centres for Disease Control and Prevention), in 2018, around 9 million adults were diagnosed with chronic bronchitis which eventually leads to higher requirements for OPEP devices, thus fueling the market. All such factors are likely to drive the growth of the global market.



Key Market Trends


COPD and Asthma Hold Significant Share in the Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market


Asthma is refered to a chronic respiratory disease which blocks the airways of lung because of mucus production, inflammation, and tightening of muscles. Similarly, Chronic Obstructive Pulmonary Disease(COPD) is caused by the blockade in the airways further resulting in difficulty in breathing, owing to the primary cause as tobacco smoking.



According to the 2018 Global Asthma Report, Auckland, New Zealand, globally, asthma is ranked 16th among the leading causes of years lived with disability and 28th among the leading causes of burden of disease, as measured by disability-adjusted life years. Around 300 million people have asthma worldwide, and it is likely that by 2025 a further 100 million may be affected. There is a large geographical variation in asthma prevalence, severity, and mortality. While asthma prevalence is higher in high income countries, most asthma-related mortality occurs in low-middle income countries.



North America Dominates the Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market


According to the 2019 report published by the Centers for Disease Control and Prevention (CDC), 1 in 13 people have asthma. More than 25 million Americans have asthma. This is 7.7% of adults and 8.4% of children. Asthma has been increasing since the early 1980s in all age, sex and racial groups.



According to the American Academy of Allergy Asthma and Immunology (AAAI), in 2016, approximately 8.3% of children in the United States were found to have asthma. Boys were to some extent more likely to have asthma than girls at a rate of 9.2% and 7.4%, respectively.



Asthma incidence among children increased from 8.7% in 2001 to 9.4% in 2010, and then declined to 8.3% in 2016. Although not all changes were statistically noteworthy, a similar outline was observed among the sub-demographic groups, except the Mexican/Mexican American children, among whom asthma prevalence increased from 5.1% in 2001 to 6.5% in 2016.



Competitive Landscape


The global Oscillating Positive Expiratory Pressure (OPEP) Devices market is competitive and consists of very few major players. Companies like AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., WyMedical Pty Ltd, among others, hold the substantial market share in the market.



Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AirPhysio
  • Allergan plc.
  • D-R Burton Healthcare
  • Medica Holdings, LLC.
  • PARI GmbH
  • R. Cegla GmbH & Co. KG

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Pulmonary Diseases
4.2.2 Growing Technological Advancements
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Face Mask PEP Devices
5.1.2 Mouthpiece PEP Devices
5.1.3 Bottle PEP Devices
5.2 By Indication
5.2.1 COPD and Asthma
5.2.2 Bronchitis
5.2.3 Cystic Fibrosis
5.2.4 Others
5.3 By End-User
5.3.1 Hospital and Clinics
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AirPhysio
6.1.2 Allergan plc.
6.1.3 D-R Burton Healthcare
6.1.4 Medica Holdings, LLC.
6.1.5 Monaghan Medical Corporation
6.1.6 PARI GmbH
6.1.7 R. Cegla GmbH & Co. KG
6.1.8 Smiths Medical, Inc.
6.1.9 WyMedical Pty Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AirPhysio
  • Allergan plc.
  • D-R Burton Healthcare
  • Medica Holdings, LLC.
  • Monaghan Medical Corporation
  • PARI GmbH
  • R. Cegla GmbH & Co. KG
  • Smiths Medical, Inc.
  • WyMedical Pty Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...